Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT05383209Phase 2Completed
Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)
Nonproliferative Diabetic Retinopathy
StudydirectorStart date: 2022-09-28

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

EyePoint Pharmaceuticals

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Alan P. Chous, O.D.

Chous Eye Care Associates

Moderately Similar
1 trials

Shared therapeutic areas:

Non-Proliferative Diabetic Retinopathy
Similarity Score30%

Seungjoon Lee, MD, Ph D

Study Official Affiliation should have no more than 80 characters.

Moderately Similar
1 trials

Shared therapeutic areas:

Non-Proliferative Diabetic Retinopathy
Similarity Score30%

Saba al Rashaed, MD

King Khaled Eye Specialist Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Non-Proliferative Diabetic Retinopathy
Similarity Score30%

Pablo Velazquez-Martin, MD

Kodiak Sciences Inc

Moderately Similar
10 trials

Shared therapeutic areas:

Non-Proliferative Diabetic Retinopathy
Similarity Score30%

Hongsheng Bi

Shandong University of Traditional Chinese Medicine Affiliated Eye Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Non-Proliferative Diabetic Retinopathy
Similarity Score30%

Wenbin Wei, MD

Beijing Tongren Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Non-Proliferative Diabetic Retinopathy
Similarity Score30%

Allen Hu, MD

Cumberland Valley Retina Consultants

Moderately Similar
1 trials

Shared therapeutic areas:

Non-Proliferative Diabetic Retinopathy
Similarity Score30%

Min Zhao, PhD

Tasly Group, Co. Ltd.

Moderately Similar
3 trials

Shared therapeutic areas:

Non-Proliferative Diabetic Retinopathy
Similarity Score30%

Hadar Shalev, M.D

Soroka University Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

Non-Proliferative Diabetic Retinopathy
Similarity Score30%

Anna Frostegård, MD, PhD

Annexin Pharmaceuticals AB

Moderately Similar
1 trials

Shared therapeutic areas:

Non-Proliferative Diabetic Retinopathy
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05383209Phase 2StudyDirector

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

Nonproliferative Diabetic Retinopathy
Completed

All 1 trials loaded